Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (313)	12/31/2000 8:59:04 PM
From: tuck	Read Replies (1) \| Respond to of 1784

PB, This is a capability of yours I did not know about. That was indeed the abstract I was trying to reference. I'm learning MedLine, etc., but obviously have room for improvement. Thanks for rising to the challenge and supplying useful pointers. I'd be totally clueless here without you guys. Thanks to the efforts of Rick, you, td, Doc Voodoo, and others, I'm only mostly clueless, a major accomplishment in such a short time. Cheers, Tuck

To: Pseudo Biologist who wrote (313)	1/1/2001 1:02:11 PM
From: tuck	Read Replies (2) \| Respond to of 1784

PB, So now I have a question for you. In the genomeweb article on BRET used as an example in the previous post, I noticed the following: >>That article, by Vanderbilt University biologist Yao Xu and his colleagues, said that BRET offers fewer cell-specific limitations and can more readily be used for high-throughput screening. But the technology also has limitations, Xu warned. The proteins may interact in such a way that the luciferase and green fluorescent protein are not close enough to exchange light energy. Hence a negative result would not prove non-interaction. But this limitation is also present in other assays, he said.<< Do you know if anybody is effectively addressing this limitation? After all, it's been almost a year. I can get the abstract at MedLine, but PNAS Online can't seem to come up with the article: >>A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc Natl Acad Sci U S A 1999 Jan 5;96(1):151-6 (ISSN: 0027-8424) Xu Y; Piston DW; Johnson CH [Find other articles with these Authors] Department of Biology, Box 1812-B, Vanderbilt University, Nashville, TN 37235, USA. We describe a method for assaying protein interactions that offers some attractive advantages over previous assays. This method, called bioluminescence resonance energy transfer (BRET), uses a bioluminescent luciferase that is genetically fused to one candidate protein, and a green fluorescent protein mutant fused to another protein of interest. Interactions between the two fusion proteins can bring the luciferase and green fluorescent protein close enough for resonance energy transfer to occur, thus changing the color of the bioluminescent emission. By using proteins encoded by circadian (daily) clock genes from cyanobacteria, we use the BRET technique to demonstrate that the clock protein KaiB interacts to form homodimers. BRET should be particularly useful for testing protein interactions within native cells, especially with integral membrane proteins or proteins targeted to specific organelles.<< snip Cheers, Tuck